91. S. Shi, B.C. Fliss, Z. Gu, Y. Zhu, H. Hong, H.F. Valdovinos et al., Chelator-free labeling of
layered double hydroxide nanoparticles for in vivo PET imaging. Sci. Rep. 5, 16930 (2015)
92. F. Chen, H. Hong, S. Goel, S.A. Graves, H. Orbay, E.B. Ehlerding et al., In vivo tumor
vasculature targeting of CuS@ MSN based theranostic nanomedicine. ACS Nano 9(4),
3926–3934 (2015)
93. M. Mahdavi, M.B. Ahmad, M.J. Haron, F. Namvar, B. Nadi, M.Z.A. Rahman et al.,
Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide
nanoparticles for biomedical applications. Molecules 18(7), 7533–7548 (2013)
94. R. Chakravarty, H.F. Valdovinos, F. Chen, C.M. Lewis, P.A. Ellison, H. Luo et al.,
Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo
dual-modality PET/MR imaging. Adv. Mater. 26(30), 5119–5123 (2014)
95. F. Chen, P.A. Ellison, C.M. Lewis, H. Hong, Y. Zhang, S. Shi et al., Chelator-free synthesis
of a dual-modality PET/MRI agent. Angew. Chem. Int. Ed. Engl. 52(50), 13319–13323
(2013)
96. A.A. Barrefelt, T.B. Brismar, G. Egri, P. Aspelin, A. Olsson, L. Oddo et al., Multimodality
imaging using SPECT/CT and MRI and ligand functionalized
99m Tc-labeled magnetic
microbubbles. EJNMMI Res. 3(1), 12 (2013)
97. J.-S. Choi, N. Meghani, Impact of surface modification in BSA nanoparticles for uptake in
cancer cells. Colloid Surf. B 145, 653–661 (2016)
98. J. Zhang, L. Lang, Z. Zhu, F. Li, G. Niu, X. Chen, Clinical translation of an albumin-binding
PET radiotracer
68
Ga-NEB. J. Nucl. Med. 56(10), 1609–1614 (2015)
99. G. Niu, L. Lang, D.O. Kiesewetter, Y. Ma, Z. Sun, N. Guo et al., In vivo labeling of serum
albumin for PET. J. Nucl. Med. 55(7), 1150–1156 (2014)
100. A. Todica, S. Brunner, G. Böning, S. Lehner, S.G. Nekolla, M. Wildgruber et al., [
68
Ga]albumin-PET in the monitoring of left ventricular function in murine models of ischemic and
dilated cardiomyopathy: comparison with cardiac MRI. Mol. Imaging Biol. 15(4), 441
(2013)
101. D.A. Heuveling, A. van Schie, D.J. Vugts, N.H. Hendrikse, M. Yaqub, O.S. Hoekstra et al.,
Pilot study on the feasibility of PET/CT lymphoscintigraphy with
89
Zr-nanocolloidal
albumin for sentinel node identification in oral cancer patients. J. Nucl. Med. 54(4), 585–589
(2013)
102. D.A. Heuveling, G.W. Visser, M. Baclayon, W.H. Roos, G.J. Wuite, O.S. Hoekstra et al.,
89
Zr-nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection
in head and neck cancer: preclinical results. J. Nucl. Med. 52(10), 1580–1584 (2011)
103. C. Perez-Medina, J. Tang, D. Abdel-Atti, B. Hogstad, M. Merad, E.A. Fisher et al., PET
imaging of tumor-associated macrophages with
89
Zr-labeled high-density lipoprotein
nanoparticles. J. Nucl. Med. 56(8), 1272–1277 (2015)
104. S. Shukla, N.F. Steinmetz, Virus-based nanomaterials as positron emission tomography and
magnetic resonance contrast agents: from technology development to translational medicine.
Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 7(5), 708–721 (2015)
105. S.M. Janib, S. Liu, R. Park, M.K. Pastuszka, P. Shi, A.S. Moses et al., Kinetic quantification
of protein polymer nanoparticles using non-invasive imaging. Integr. Biol. 5(1), 183–194
(2013)
106. D. Sleep, Albumin and its application in drug delivery. Expert Opin. Drug Deliv. 12(5),
793–812 (2015)
107. D. Sleep, J. Cameron, L.R. Evans, Albumin as a versatile platform for drug half-life
extension. Biochim. Biophys. Acta 1830(12), 5526–5534 (2013)
108. E. Frei, Albumin binding ligands and albumin conjugate uptake by cancer cells. Diabetol.
Metab. Syndr. 3(1), 11 (2011)
109. N.N. Davanzo, D.S. Pellosi, L.P. Franchi, A.C. Tedesco, Light source is critical to induce
glioblastoma cell death by photodynamic therapy using chloro-aluminiumphtalocyanine
albumin-based nanoparticles. Photodiagn. Photodyn. Ther. 19, 181–183 (2017)
10 Surface Modification of Radionanomedicine
205
layered double hydroxide nanoparticles for in vivo PET imaging. Sci. Rep. 5, 16930 (2015)
92. F. Chen, H. Hong, S. Goel, S.A. Graves, H. Orbay, E.B. Ehlerding et al., In vivo tumor
vasculature targeting of CuS@ MSN based theranostic nanomedicine. ACS Nano 9(4),
3926–3934 (2015)
93. M. Mahdavi, M.B. Ahmad, M.J. Haron, F. Namvar, B. Nadi, M.Z.A. Rahman et al.,
Synthesis, surface modification and characterisation of biocompatible magnetic iron oxide
nanoparticles for biomedical applications. Molecules 18(7), 7533–7548 (2013)
94. R. Chakravarty, H.F. Valdovinos, F. Chen, C.M. Lewis, P.A. Ellison, H. Luo et al.,
Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo
dual-modality PET/MR imaging. Adv. Mater. 26(30), 5119–5123 (2014)
95. F. Chen, P.A. Ellison, C.M. Lewis, H. Hong, Y. Zhang, S. Shi et al., Chelator-free synthesis
of a dual-modality PET/MRI agent. Angew. Chem. Int. Ed. Engl. 52(50), 13319–13323
(2013)
96. A.A. Barrefelt, T.B. Brismar, G. Egri, P. Aspelin, A. Olsson, L. Oddo et al., Multimodality
imaging using SPECT/CT and MRI and ligand functionalized
99m Tc-labeled magnetic
microbubbles. EJNMMI Res. 3(1), 12 (2013)
97. J.-S. Choi, N. Meghani, Impact of surface modification in BSA nanoparticles for uptake in
cancer cells. Colloid Surf. B 145, 653–661 (2016)
98. J. Zhang, L. Lang, Z. Zhu, F. Li, G. Niu, X. Chen, Clinical translation of an albumin-binding
PET radiotracer
68
Ga-NEB. J. Nucl. Med. 56(10), 1609–1614 (2015)
99. G. Niu, L. Lang, D.O. Kiesewetter, Y. Ma, Z. Sun, N. Guo et al., In vivo labeling of serum
albumin for PET. J. Nucl. Med. 55(7), 1150–1156 (2014)
100. A. Todica, S. Brunner, G. Böning, S. Lehner, S.G. Nekolla, M. Wildgruber et al., [
68
Ga]albumin-PET in the monitoring of left ventricular function in murine models of ischemic and
dilated cardiomyopathy: comparison with cardiac MRI. Mol. Imaging Biol. 15(4), 441
(2013)
101. D.A. Heuveling, A. van Schie, D.J. Vugts, N.H. Hendrikse, M. Yaqub, O.S. Hoekstra et al.,
Pilot study on the feasibility of PET/CT lymphoscintigraphy with
89
Zr-nanocolloidal
albumin for sentinel node identification in oral cancer patients. J. Nucl. Med. 54(4), 585–589
(2013)
102. D.A. Heuveling, G.W. Visser, M. Baclayon, W.H. Roos, G.J. Wuite, O.S. Hoekstra et al.,
89
Zr-nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection
in head and neck cancer: preclinical results. J. Nucl. Med. 52(10), 1580–1584 (2011)
103. C. Perez-Medina, J. Tang, D. Abdel-Atti, B. Hogstad, M. Merad, E.A. Fisher et al., PET
imaging of tumor-associated macrophages with
89
Zr-labeled high-density lipoprotein
nanoparticles. J. Nucl. Med. 56(8), 1272–1277 (2015)
104. S. Shukla, N.F. Steinmetz, Virus-based nanomaterials as positron emission tomography and
magnetic resonance contrast agents: from technology development to translational medicine.
Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 7(5), 708–721 (2015)
105. S.M. Janib, S. Liu, R. Park, M.K. Pastuszka, P. Shi, A.S. Moses et al., Kinetic quantification
of protein polymer nanoparticles using non-invasive imaging. Integr. Biol. 5(1), 183–194
(2013)
106. D. Sleep, Albumin and its application in drug delivery. Expert Opin. Drug Deliv. 12(5),
793–812 (2015)
107. D. Sleep, J. Cameron, L.R. Evans, Albumin as a versatile platform for drug half-life
extension. Biochim. Biophys. Acta 1830(12), 5526–5534 (2013)
108. E. Frei, Albumin binding ligands and albumin conjugate uptake by cancer cells. Diabetol.
Metab. Syndr. 3(1), 11 (2011)
109. N.N. Davanzo, D.S. Pellosi, L.P. Franchi, A.C. Tedesco, Light source is critical to induce
glioblastoma cell death by photodynamic therapy using chloro-aluminiumphtalocyanine
albumin-based nanoparticles. Photodiagn. Photodyn. Ther. 19, 181–183 (2017)
10 Surface Modification of Radionanomedicine
205